18947390

Source:http://linkedlifedata.com/resource/pubmed/id/18947390

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0006142, umls-concept:C0220901, umls-concept:C0237881, umls-concept:C0279781, umls-concept:C0750502, umls-concept:C1521970
pubmed:dateCreated	2008-11-4
pubmed:abstractText	Triple-negative (TN) breast cancer, which is defined as being negative for the estrogen receptor (ER), the progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER-2), represents a subset of breast cancer with different biologic behaviour. We investigated the clinicopathologic characteristics and prognostic indicators of lymph node-negative TN breast cancer.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/18947390-10942052, http://linkedlifedata.com/resource/pubmed/commentcorrection/18947390-10963602, http://linkedlifedata.com/resource/pubmed/commentcorrection/18947390-11553815, http://linkedlifedata.com/resource/pubmed/commentcorrection/18947390-11745185, http://linkedlifedata.com/resource/pubmed/commentcorrection/18947390-12829800, http://linkedlifedata.com/resource/pubmed/commentcorrection/18947390-14718270, http://linkedlifedata.com/resource/pubmed/commentcorrection/18947390-14871808, http://linkedlifedata.com/resource/pubmed/commentcorrection/18947390-15328174, http://linkedlifedata.com/resource/pubmed/commentcorrection/18947390-15510162, http://linkedlifedata.com/resource/pubmed/commentcorrection/18947390-15829967, http://linkedlifedata.com/resource/pubmed/commentcorrection/18947390-15955736, http://linkedlifedata.com/resource/pubmed/commentcorrection/18947390-16033833, http://linkedlifedata.com/resource/pubmed/commentcorrection/18947390-16236737, http://linkedlifedata.com/resource/pubmed/commentcorrection/18947390-16236738, http://linkedlifedata.com/resource/pubmed/commentcorrection/18947390-16341146, http://linkedlifedata.com/resource/pubmed/commentcorrection/18947390-16757721, http://linkedlifedata.com/resource/pubmed/commentcorrection/18947390-16938528, http://linkedlifedata.com/resource/pubmed/commentcorrection/18947390-17016441, http://linkedlifedata.com/resource/pubmed/commentcorrection/18947390-17116942, http://linkedlifedata.com/resource/pubmed/commentcorrection/18947390-17146782, http://linkedlifedata.com/resource/pubmed/commentcorrection/18947390-17208639, http://linkedlifedata.com/resource/pubmed/commentcorrection/18947390-17329194, http://linkedlifedata.com/resource/pubmed/commentcorrection/18947390-17387718, http://linkedlifedata.com/resource/pubmed/commentcorrection/18947390-17430582, http://linkedlifedata.com/resource/pubmed/commentcorrection/18947390-17438091, http://linkedlifedata.com/resource/pubmed/commentcorrection/18947390-1757079, http://linkedlifedata.com/resource/pubmed/commentcorrection/18947390-17671126, http://linkedlifedata.com/resource/pubmed/commentcorrection/18947390-17976237, http://linkedlifedata.com/resource/pubmed/commentcorrection/18947390-6165237, http://linkedlifedata.com/resource/pubmed/commentcorrection/18947390-8096955, http://linkedlifedata.com/resource/pubmed/commentcorrection/18947390-8098946, http://linkedlifedata.com/resource/pubmed/commentcorrection/18947390-8164038
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/100967800
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/EGFR protein, human, http://linkedlifedata.com/resource/pubmed/chemical/ERBB2 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Estrogen Receptor alpha, http://linkedlifedata.com/resource/pubmed/chemical/Ki-67 Antigen, http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-bcl-2, http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Epidermal Growth Factor, http://linkedlifedata.com/resource/pubmed/chemical/Receptor, erbB-2, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Progesterone, http://linkedlifedata.com/resource/pubmed/chemical/Tumor Suppressor Protein p53
pubmed:status	MEDLINE
pubmed:issn	1471-2407
pubmed:author	pubmed-author:BangYung-JueYJ, pubmed-author:HanSae-WonSW, pubmed-author:HanWonshikW, pubmed-author:ImSeock-AhSA, pubmed-author:KimJee HyunJH, pubmed-author:KimTae-YouTY, pubmed-author:NohDong-YoungDY, pubmed-author:OhDo-YounDY, pubmed-author:ParkIn AeIA, pubmed-author:RheeJiyoungJ
pubmed:issnType	Electronic
pubmed:volume	8
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	307
pubmed:dateRevised	2010-11-18
pubmed:meshHeading	pubmed-meshheading:18947390-Adult, pubmed-meshheading:18947390-Aged, pubmed-meshheading:18947390-Aged, 80 and over, pubmed-meshheading:18947390-Breast, pubmed-meshheading:18947390-Breast Neoplasms, pubmed-meshheading:18947390-Estrogen Receptor alpha, pubmed-meshheading:18947390-Female, pubmed-meshheading:18947390-Humans, pubmed-meshheading:18947390-Immunohistochemistry, pubmed-meshheading:18947390-Kaplan-Meier Estimate, pubmed-meshheading:18947390-Ki-67 Antigen, pubmed-meshheading:18947390-Korea, pubmed-meshheading:18947390-Male, pubmed-meshheading:18947390-Middle Aged, pubmed-meshheading:18947390-Multivariate Analysis, pubmed-meshheading:18947390-Neoplasm Recurrence, Local, pubmed-meshheading:18947390-Prognosis, pubmed-meshheading:18947390-Proto-Oncogene Proteins c-bcl-2, pubmed-meshheading:18947390-Receptor, Epidermal Growth Factor, pubmed-meshheading:18947390-Receptor, erbB-2, pubmed-meshheading:18947390-Receptors, Progesterone, pubmed-meshheading:18947390-Tumor Suppressor Protein p53
pubmed:year	2008
pubmed:articleTitle	The clinicopathologic characteristics and prognostic significance of triple-negativity in node-negative breast cancer.
pubmed:affiliation	Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea. splendor97@gmail.com
pubmed:publicationType	Journal Article